نتائج البحث - Matthias Holdhoff

تنقيح النتائج
  1. 1
    Actionable Molecular Biomarkers in Primary Brain Tumors

    Actionable Molecular Biomarkers in Primary Brain Tumors حسب Verena Staedtke, Omar Dzaye, Matthias Holdhoff

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Systemic use of tumor necrosis factor alpha as an anticancer agent

    Systemic use of tumor necrosis factor alpha as an anticancer agent حسب Nicholas J. Roberts, Shibin Zhou, Luis A. Díaz, Matthias Holdhoff

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Ipilimumab-Induced Enteritis without Colitis: A New Challenge

    Ipilimumab-Induced Enteritis without Colitis: A New Challenge حسب Marcus Messmer, Sunita Upreti, Yaman Tarabishy, Nikhilesh R. Mazumder, Reezwana Chowdhury, Mark Yarchoan, Matthias Holdhoff

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas

    Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas حسب Karisa C. Schreck, Surabhi Ranjan, Nebojša Skorupan, Chetan Bettegowda, Charles G. Eberhart, Heather M. Ames, Matthias Holdhoff

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

    High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma حسب Matthias Holdhoff, Prakash Ambady, Ahmed Abdelaziz, Guneet Sarai, David Bonekamp, Jaishri O. Blakeley, Stuart A. Grossman, Xiaobu Ye

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma

    Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma حسب Matthias Holdhoff, Maciej M. Mrugała, Christian Grommes, Thomas Kaley, Lode J. Swinnen, Carlos A. Perez-Heydrich, Lakshmi Nayak

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Prostate-Specific Membrane Antigen–Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas

    Prostate-Specific Membrane Antigen–Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas حسب Roberto A. Salas Fragomeni, Joshua Menke, Matthias Holdhoff, C Ferrigno, John Laterra, Lilja B. Sólnes, Mehrbod S. Javadi, Zsolt Szabó, Martin G. Pomper, Steven P. Rowe

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas

    Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas حسب Hatim Husain, William Savage, Stuart A. Grossman, Xiaobu Ye, Peter C. Burger, Allen D. Everett, Chetan Bettegowda, Luis A. Díaz, Cheríe Blair, Katharine Romans, Matthias Holdhoff

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor

    Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor حسب Matthias Holdhoff, Karl-Anton Kreuzer, Christine Appelt, Regina Scholz, Il‐Kang Na, Bert Hildebrandt, Hanno Riess, Andreas Jordan, Christian Schmidt, Richard A. Van Etten, Bernd Dörken, Philipp le Coutre

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

    Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β حسب Kajal Chaudhry, Ashley Geiger, Ehsan Dowlati, Haili Lang, Danielle Sohai, Eugene Hwang, Christopher A. Lazarski, Eric Yvon, Matthias Holdhoff, R. Brad Jones, Barbara Savoldo, Conrad Russell Y. Cruz, Catherine M. Bollard

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas

    Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas حسب Jian L. Campian, Xiaobu Ye, Douglas E. Gladstone, Prakash Ambady, Thomas R. Nirschl, Ivan Borrello, Marc G. Golightly, Karen E. King, Matthias Holdhoff, Judith E. Karp, Charles G. Drake, Stuart A. Grossman

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and <i>In Situ</i> Hybridization

    Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and <i>In Situ</i> Hybridization حسب Matthias Holdhoff, Güneş Güner, Fausto J. Rodríguez, Jessica Hicks, Qizhi Zheng, Michael Forman, Xiaobu Ye, Stuart A. Grossman, Alan K. Meeker, Christopher M. Heaphy, Charles G. Eberhart, Angelo M. De Marzo, Ravit Arav‐Boger

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas

    Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas حسب Matthias Holdhoff, Xiaobu Ye, Jeffrey G. Supko, Burt Nabors, Arati Desai, Tobias Walbert, Glenn J. Lesser, William L. Read, Frank S. Lieberman, Martin A. Lodge, Jeffrey P. Leal, Joy Fisher, Serena Desideri, Stuart A. Grossman, Richard L. Wahl, David Schiff

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

    Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced canc... حسب Jordi Rodón, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, Analía Azaro, Emiliano Calvo, Joan Seoane, Irene Braña, Elisabet Sicart, Ivelina Gueorguieva, Ann Cleverly, Nischalan Pillay, D. Desaiah, Shawn T. Estrem, Luis Paz‐Ares, Matthias Holdhoff, Jaishri O. Blakeley, Michael Lahn, José Baselga

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

    First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma حسب Jordi Rodón, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, Analía Azaro, Emiliano Calvo, Joan Seoane, Irene Braña, Elisabet Sicart, Ivelina Gueorguieva, Ann Cleverly, N. Sokalingum Pillay, D. Desaiah, Shawn T. Estrem, Luis Paz‐Ares, Matthias Holdhoff, Jaishri O. Blakeley, Michael Lahn, José Baselga

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium

    Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium حسب Omar Dzaye, Ramzi Dudum, Mohammadhassan Mirbolouk, Olusola A. Orimoloye, Albert D. Osei, Zeina Dardari, Daniel S. Berman, Michael D. Miedema, Leslee J. Shaw, Alan Rozanski, Matthias Holdhoff, Khurram Nasir, John A. Rumberger, Matthew J. Budoff, Mouaz H. Al‐Mallah, Ron Blankstein, Michael J. Blaha

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes

    Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes حسب Aanika Balaji, Jiajia Zhang, Beatriz Wills, Kristen A. Marrone, Hany Elmariah, Mark Yarchoan, Jacquelyn W. Zimmerman, Khalid Hajjir, Deepti Venkatraman, Deborah K. Armstrong, Daniel A. Laheru, Ranee Mehra, Won Jin Ho, Joshua E. Reuss, Joseph Heng, Paz J. Vellanki, Ross C. Donehower, Matthias Holdhoff, Jarushka Naidoo

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma

    A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma حسب Karthik Ramesh, Eric A. Mellon, Saumya Gurbani, Brent D. Weinberg, Eduard Schreibmann, Sulaiman Sheriff, Mohammed Goryawala, Macarena de le Fuente, Bree R. Eaton, Jim Zhong, Alfredo Voloschin, Soma Sengupta, Erin Dunbar, Matthias Holdhoff, Peter B. Barker, Andrew A. Maudsley, Lawrence Kleinberg, Hyunsuk Shim, Hui‐Kuo G. Shu

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

    Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma حسب Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Elizabeth A. Maher, Macarena I. de la Fuente, Matthias Holdhoff, Gregory M. Coté, Howard A. Burris, Filip Janků, Robert J. Young, Raymond Y. Huang, Liewen Jiang, Sung Choe, Bin Fan, Katharine Yen, Min Lu, Chris Bowden, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers حسب Jarushka Naidoo, Karisa C. Schreck, Wei Fu, Chen Hu, Alexander Carvajal-González, Roisín M. Connolly, Cesar A. Santa‐Maria, Evan J. Lipson, Matthias Holdhoff, Patrick M. Forde, Christopher Douville, Joanne Riemer, Amanda Barnes, Kristin J. Redmond, Lawrence Kleinberg, B.R. Page, Nafi Aygün, Kenneth W. Kinzler, Nickolas Papadopoulos, Chetan Bettegowda, Arun Venkatesan, Julie R. Brahmer, Stuart A. Grossman

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: